Larvol Delta - ATTAINNOW-A-Study-of-Orforglipron-in-Participants-With-Overweight-at-Risk-of-Development-of-ObesityRelated-Complications-or-Progression-to-Class-1-Obesity

Foundayo (orforglipron) - Eli Lilly

http://clinicaltrials.gov/ct2/show/NCT07794579

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next